Previous Section
Clinical Trials
1. Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study.
- Author
- Prikryl R; Kasparek T; Skotakova S; Ustohal L; Kucerova H; Ceskova E; Prikryl R; Kasparek T; Skotakova S; Ustohal L; Kucerova H; Ceskova E;
- Institution
- Department of Psychiatry, Masaryk University, Faculty of Medicine and Faculty Hospital, Jihlavska 20, 625 00 Brno, Czech Republic. radovan.prikryl@post.cz
- Journal
- Schizophr Res. 2007 Sep;95(1-3):151-7. Epub 2007 Aug 8.
- Abstract URL
- Click here to view abstract
2. A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia.
- Author
- Luthringer R; Staner L; Noel N; Muzet M; Gassmann-Mayer C; Talluri K; Cleton A; Eerdekens M; Battisti WP; Palumbo JM;
- Institution
- Executive Department, Forenap Pharma, 27 rue du 4eme RSM, Rouffach 68250, France. remy.luthringer@forenap.com
- Journal
- Int Clin Psychopharmacol. 2007 Sep;22(5):299-308.
- Abstract URL
- Click here to view abstract
3. No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia.
- Author
- Kohler CG; Martin EA; Kujawski E; Bilker W; Gur RE; Gur RC; Kohler CG; Martin EA; Kujawski E; Bilker W; Gur RE; Gur RC;
- Institution
- Schizophrenia Research Center, Neuropsychiatry Section, University of Pennsylvania, Philadelphia, PA, USA.
- Journal
- Cognit Neuropsychiatry. 2007 Sep;12(5):412-21.
- Abstract URL
- Click here to view abstract
4. Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: A randomized, open-label, controlled trial.
- Author
- Kim SW; Shin IS; Kim JM; Lee SH; Lee JH; Yoon BH; Yang SJ; Hwang MY; Yoon JS;
- Institution
- Department of Psychiatry, Chonnam National University Medical School, 5 Hak-dong, Dong-gu, Gwangju 501-746, Republic of Korea; Clinical Trial Center, Chonnam National University Hospital, 8 Hak-dong, Dong-gu, Gwangju 501-757, Republic of Korea.
- Journal
- Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jul 13;.
- Abstract URL
- Click here to view abstract
5. Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial.
- Author
- Wynn JK; Green MF; Sprock J; Light GA; Widmark C; Reist C; Erhart S; Marder SR; Mintz J; Braff DL;
- Institution
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA. jkwynn@ucla.edu
- Journal
- Schizophr Res. 2007 Sep;95(1-3):134-42. Epub 2007 Jul 26.
- Abstract URL
- Click here to view abstract
6. Long-acting injectable risperidone v. olanzapine tablets for schizophrenia or schizoaffective disorder: Randomised, controlled, open-label study.
- Author
- Keks NA; Ingham M; Khan A; Karcher K;
- Institution
- Delmont Hospital, 298 Warrigal Road, Glen Iris, VIC 3146, Australia. Nicholas.keks@med.monash.edu.au.
- Journal
- Br J Psychiatry. 2007 Aug;191:131-9.
- Abstract URL
- Click here to view abstract
7. A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA).
- Author
- Wolf J; Janssen F; Lublin H; Salokangas RK; Allain H; Smeraldi E; Bernardo M; Millar H; Pans M; Adelbrecht C; Laughton J; Werner C; Maier W;
- Institution
- Journal
- Curr Med Res Opin. 2007 Aug 16;.
- Abstract URL
- Click here to view abstract
8. Clozapine treatment of childhood-onset schizophrenia: evaluation of effectiveness, adverse effects, and long-term outcome.
- Author
- Sporn AL; Vermani A; Greenstein DK; Bobb AJ; Spencer EP; Clasen LS; Tossell JW; Stayer CC; Gochman PA; Lenane MC; Rapoport JL; Gogtay N;
- Institution
- Child Psychiatry Branch, NIMH, Bethesda, MD, USA. als2168@columbia.edu
- Journal
- J Am Acad Child Adolesc Psychiatry. 2007 Oct;46(10):1349-56.
- Abstract URL
- Click here to view abstract
9. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.
- Author
- Buchanan RW; Javitt DC; Marder SR; Schooler NR; Gold JM; McMahon RP; Heresco-Levy U; Carpenter WT;
- Institution
- Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD 21228, USA.
- Journal
- Am J Psychiatry. 2007 Oct;164(10):1593-602.
- Abstract URL
- Click here to view abstract
10. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?
- Author
- Goldberg TE; Goldman RS; Burdick KE; Malhotra AK; Lencz T; Patel RC; Woerner MG; Schooler NR; Kane JM; Robinson DG;
- Institution
- Zucker Hillside Hospital, 7559 263rd Street, Glen Oaks, NY 11004, USA. tgoldber@nshs.edu
- Journal
- Arch Gen Psychiatry. 2007 Oct;64(10):1115-22.
- Abstract URL
- Click here to view abstract
Next: Complementary Medicine
